These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21967874)

  • 21. HIV-associated pediatric tuberculosis: prevention, diagnosis and treatment.
    Kay A; Garcia-Prats AJ; Mandalakas AM
    Curr Opin HIV AIDS; 2018 Nov; 13(6):501-506. PubMed ID: 30286040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
    Briggs MA; Emerson C; Modi S; Taylor NK; Date A
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV and tuberculosis--science and implementation to turn the tide and reduce deaths.
    Harries AD; Lawn SD; Getahun H; Zachariah R; Havlir DV
    J Int AIDS Soc; 2012; 15(2):17396. PubMed ID: 22905358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions to improve linkage along the HIV-tuberculosis care cascades in low- and middle-income countries: A systematic review and meta-analysis.
    Salomon A; Law S; Johnson C; Baddeley A; Rangaraj A; Singh S; Daftary A
    PLoS One; 2022; 17(5):e0267511. PubMed ID: 35552547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global epidemiology of tuberculosis: prospects for control.
    Lönnroth K; Raviglione M
    Semin Respir Crit Care Med; 2008 Oct; 29(5):481-91. PubMed ID: 18810682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stopping tuberculosis in the 21st century: goals and strategies.
    Onozaki I; Raviglione M
    Respirology; 2010 Jan; 15(1):32-43. PubMed ID: 20199633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Operational research to improve HIV prevention in the United States.
    Herbst JH; Glassman M; Carey JW; Painter TM; Gelaude DJ; Fasula AM; Raiford JL; Freeman AE; Harshbarger C; Viall AH; Purcell DW
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):530-6. PubMed ID: 22217681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From HIV to tuberculosis and back again: a tale of activism in 2 pandemics.
    Harrington M
    Clin Infect Dis; 2010 May; 50 Suppl 3():S260-6. PubMed ID: 20397957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries.
    Gupta S; Granich R; Date A; Lepere P; Hersh B; Gouws E; Samb B
    Int J Tuberc Lung Dis; 2014 Oct; 18(10):1149-58. PubMed ID: 25216827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculosis-a World Health Organization Perspective.
    Sotgiu G; Sulis G; Matteelli A
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gaps in tuberculosis control in Armenia: How to improve the care system?
    Davtyan H; Petrosyan A; Aslanyan G; Aghabekyan S; De Basso D; Davtyan K
    J Infect Dev Ctries; 2020 Nov; 14(11.1):133S-139S. PubMed ID: 33226972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying research questions for HIV, tuberculosis, tuberculosis-HIV, malaria, and neglected tropical diseases through the World Health Organization guideline development process: a retrospective analysis, 2008-2018.
    Hargreaves S; Himmels J; Nellums LB; Biswas G; Gabrielli AF; Gebreselassie N; Zignol M; Schellenberg D; Norris SL; Ford N; Maher D
    Public Health; 2020 Oct; 187():19-23. PubMed ID: 32889228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuberculosis into the 2010s: is the glass half full?
    Ralph AP; Anstey NM; Kelly PM
    Clin Infect Dis; 2009 Aug; 49(4):574-83. PubMed ID: 19583517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of operational research into National Tuberculosis Control Programmes.
    Harries AD
    Tuberculosis (Edinb); 2003; 83(1-3):143-7. PubMed ID: 12758204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services.
    Getahun H; Gunneberg C; Sculier D; Verster A; Raviglione M
    Curr Opin HIV AIDS; 2012 Jul; 7(4):345-53. PubMed ID: 22678489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis and HIV-infection in developing countries.
    Broekmans JF
    Trop Geogr Med; 1991 Jul; 43(3):S13-21. PubMed ID: 1687768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scaling up of HIV-TB collaborative activities: Achievements and challenges in India.
    Deshmukh R; Shah A; Sachdeva KS; Sreenivas AN; Gupta RS; Khaparde SD
    Indian J Tuberc; 2016 Jan; 63(1):4-7. PubMed ID: 27235937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of the HIV epidemic on tuberculosis control programmes in developing countries.
    Veeken H; Bermejo A
    Trop Doct; 1992 Apr; 22(2):64-7. PubMed ID: 1344023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis & treatment of tuberculosis in HIV co-infected patients.
    Padmapriyadarsini C; Narendran G; Swaminathan S
    Indian J Med Res; 2011 Dec; 134(6):850-65. PubMed ID: 22310818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.